Business
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDAFirst Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth of 10.0%Gross margin of 79.8% Net loss of $4.3 million, representing an improvement of 33.8% Adjusted EBITDA of $2.5 million, representing an improvement of over 440%$144.7 million in cash
About this update from Si-bone, Inc.
[{"type":"image","alt":"SI-BONE, Inc.","displaySize":"","headline":null,"caption":"SI-BONE, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":155,"height":88,"url":"https://media.zenfs.com/en/globenewswire.com/28b63324ec5b28defa8d8a8f81250704"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/aNz_YQVUQ.ijkGc8WUObEg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTExOQ--/https://media.zenfs.com/en/globenewswire.com/28b63324ec5b28defa8d8a8f81250704","width":155,"height":88},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/aNz_YQVUQ.ijkGc8WUObEg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTExOQ--/https://media.zenfs.com/en/globenewswire.com/28b63324ec5b28defa8d8a8f81250704","width":155,"height":88}},"lazy":false},{"type":"text","content":"Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA","length":109,"tagName":"p"},{"type":"text","content":"First Quarter 2026 Financial Highlights (all comparisons are to the prior year period)","length":86,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Worldwide revenue of $52.6 million, representing growth of 11.2%","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"U.S. revenue of $49.3 million, representing growth of 10.0%","length":59,"tagName":"p"}]},{"val":[{"type":"text","content":"Gross margin of 79.8%","length":21,"tagName":"p"}]},{"val":[{"type":"text","content":"Net loss of $4.3 million, representing an improvement of 33.8%","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA of $2.5 million, representing an improvement of over 440%","length":73,"tagName":"p"}]},{"val":[{"type":"text","content":"$144.7 million in cash and equivalents","length":38,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":317,"olType":false},{"type":"text","content":"Recent Operational Highlights (any comparisons are to the prior year period)","length":76,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Over 1,650 active U.S. physicians, representing growth of 17%","length":61,"tagName":"p"}]},{"val":[{"type":"text","content":"$2.2 million in trailing 12-month average revenue per territory, representing an increase of 11%","length":96,"tagName":"p"}]},{"val":[{"type":"text","content":"Expanded international presence with the launch of iFuse TORQ TNT in Europe and iFuse ...